UTMDUTAH MEDICAL PRODUCTS INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $39M
- 5.8% YoY
- Operating margin
- 29.6%
- 11% YoY
- EBITDA
- $12M
- 15% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -7.1×
- −$87M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear84% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear11% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $49M | $52M | $50M | $41M | $39M | 5.8% |
| Operating income | $19M | $20M | $17M | $14M | $11M | 16% |
| Operating cash flow | $21M | $21M | $22M | $15M | $15M | 0.9% |
| Capex | $552K | $809K | $639K | $230K | $371K | 61% |
| Stock-based comp | $166K | $183K | $225K | $256K | $373K | 46% |
| Buybacks | $0 | $2M | $0 | $20M | $8M | 58% |
| Dividends | $11M | $3M | $4M | $4M | $4M | 6.5% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $67K · 1
- Open-market sells, 12 mo
- $0 · 0
- Net
- $67K
Pay vs performance
No pay-versus-performance disclosure yet.